National Lipid Association
National Lipid Association
May 20, 2016
3 min watch

VIDEO: NLA official discusses presentations of interest at annual scientific sessions

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

NEW ORLEANS — In this video, Peter Jones, MD, FNLA, associate professor of medicine/atherosclerosis and lipidology at Baylor College of Medicine, and Chief Science Officer for the National Lipid Association, discusses highlighted presentations from the NLA Annual Scientific Sessions.

“We’ve got a great session here that’s going to cover all the latest information and data pertaining to clinical lipidology,” Jones told Cardiology Today.

Among those sessions discussed are two keynote sessions: one focusing on apoplipoprotein C-III and its role in lipid metabolism, and another on management and pathogenesis of non-alcoholic fatty liver disease.

Additionally, Jones said, a masters course on LDL receptor was introduced for the first time at the sessions. Focusing on genetic factors often seen in patients with autosomal-dominant hypercholesterolemia, the course examines new drugs and drugs in development designed to manipulate the LDL receptor to improve dyslipidemia.